CDKN2B-AS1 was significantly upregulated in ccRCC and participated in epigenetic activation of NUF2. Thus, it enhanced NUF2 transcription, which promoted tumor cell growth and metastasis both in vitro and in vivo. This evidence concerns the gene CDKN2B and nonpapillary renal cell carcinoma.